SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (1689)7/1/2003 9:25:55 PM
From: Spekulatius  Read Replies (1) | Respond to of 3044
 
Pharma cost in the US are:
30% Sales and Marketing
30% Profit (pretax)
15% Production cost
15% R&D
10% legal costs
These are my estimates based on large pharma income statements. The legal cost are unknown and they are hidden in SG&A but also in R&D (more thorough testing).
There are huge opportunities to reduce costs in developing countries and still make good profit margins.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News